Securities code: 002957 securities abbreviation: Shenzhen Colibri Technologies Co.Ltd(002957) Announcement No.: 2022-004 Shenzhen Colibri Technologies Co.Ltd(002957)
2021 annual performance forecast
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. 1、 Expected performance of the current period
1. Performance forecast period: from January 1, 2021 to December 31, 2021.
2. Expected performance: □ turn loss into profit □ increase in the same direction √ decrease in the same direction
The current reporting period of the project is the same period of last year
Profit attributable to listed companies: 55 million yuan – 80 million yuan
Profit: 293.1586 million yuan. The net profit of shareholders decreased by 72.71% – 81.24% over the same period of last year
Profit after deducting non recurring losses: 17 million yuan – 25 million yuan
Profit: the net profit after profit of 242.1761 million yuan decreased by 89.68% – 92.98% over the same period of last year
Operating income: 2.0 million yuan – 220 million yuan 2014349400 yuan
Basic earnings per share: 0.13 yuan / share -0.19 yuan / share; earnings per share: 0.72 yuan / share
2、 Performance forecast and pre audit
This performance forecast is the preliminary calculation result of the company’s financial department and has not been pre audited by an accounting firm. The company has made pre communication with the company’s 2021 financial audit institution on matters related to the performance forecast, and there is no significant difference between the two sides on the performance forecast. 3、 Explanation of performance change reasons
In 2021, the company carried out business activities around the 3 + n business strategy. The operation of the three main businesses was in good condition, and the phased objectives such as sales scale, profit realization and business line expansion reached the planning expectations. The company has increased R & D investment in power lithium battery equipment in the field of new energy, actively expanded core customers in the industry, and completed the merger and acquisition of the volume division target of the core process of lithium battery production. As of the date of this announcement, the company’s new energy lithium battery equipment business has a total order of more than 1.8 billion yuan. However, class n businesses, mainly including medical treatment, logistics, new retail and e-cigarettes, failed to meet expectations due to the impact of the investment rhythm of downstream customers during the epidemic period, and the revenue and performance fell sharply, affecting the overall performance of the company.
The reasons for the decrease of net profit attributable to shareholders of listed companies from January to December 2021 compared with the same period of last year mainly include:
1. During the development and accumulation period of new energy strategic business, the comprehensive gross profit margin was affected: in 2021, the company focused on the development of new energy power lithium battery equipment business, achieved phased results, and the business proportion increased. However, due to the comprehensive factors such as the low gross profit margin during the development period of power lithium battery equipment business and the rise of raw material prices and labor costs during the reporting period, In 2021, the company’s comprehensive gross profit margin decreased by more than 5% year-on-year. With the improvement of strategic business scale and maturity, the cost of supply chain continues to be optimized, and the business profitability will be gradually improved.
2. Take the initiative to increase the investment in R & D and management of main business, with a significant increase in expenses: in 2021, the company increased R & D investment, focusing on the production equipment of the middle and rear section of new energy power lithium battery, mobile terminal AR / VR related detection and equipment equipment, camera module detection equipment and other series of products. The R & D investment increased by more than 100 million yuan compared with the same period last year, Among them, the R & D personnel increased by 48% compared with the same period last year, and the overall R & D expenses, management expenses and sales expenses increased significantly year-on-year.
3. Sort out and evaluate the business lines and investment projects that fail to meet the expectations, and prudently calculate and withdraw impairment losses: in the fourth quarter of 2021, the company sorted out and closed the businesses with slow progress, poor expected growth, low profitability and high operational risk, and conducted impairment tests on relevant business assets. The total impairment losses accrued exceeded 30 million yuan. The company participated in Wuhan lotford Power Technology Co., Ltd. in 2020. Its performance did not meet expectations in 2021. The company assessed its impairment according to the principle of prudence, which is expected to be no more than 30 million yuan. 4、 Risk tips
1. This performance forecast is the preliminary calculation result of the company’s financial department. Without the audit of the audit institution, the specific data of 2021 performance will be disclosed in detail in the company’s 2021 annual report.
2. Please make careful decisions and pay attention to investment risks.
It is hereby announced.
Shenzhen Colibri Technologies Co.Ltd(002957) board of directors
January 29, 2022
